Clinical trial
Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
NCT00143559 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00143559 |
|---|---|
| Title | Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies |
| Official title | Haploidentical Hematopoietic Stem Cell Transplantation Utilizing Partial T-Cell Depletion as Immunotherapy for Hematologic Malignancies |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Paroxysmal Nocturnal Hemoglobinuria, Hodgkin's Lymphoma, Non-Hodgkin Lymphoma |
| Intervention type | Device, Drug, Procedure |
| Interventions | Systematic chemotherapy and antibodies, Allogeneic stem cell transplantation, Miltenyi CliniMACS |
| Enrollment | 17 |
| Start date | Aug 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Jan 1, 2009 |
| First posted | Sep 2, 2005 |
| Last update posted | Jan 29, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: